- 1次围观
产品图片
货号/SKU
NR-52244
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52244??Acinetobacter baumannii, MRSN 480561 (Bacteria)|Acinetobacter baumannii|MRSN 480561 |-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 480561, NR-52244. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 480561 was isolated in 2017 from a human respiratory sample in Asia as part of a global surveillance program.
A. baumannii, strain MRSN 480561 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52244 was deposited as multi-locus sequence type (MLST) ST 25, sensitive to colistin and tetracycline and resistant to amikacin, ampicillin/sulbactam, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, gentamicin, imipenem, levofloxacin, meropenem, tobramycin and trimethoprim/sulfamethoxazole. Strain MRSN 480561 is reported to have five aminoglycoside transferase genes [aac(3)-IIa, aac(6')-Ian, aph(3'')-Ib, aph(6)-Id and armA; conferring resistance to various aminoglycosides], one rifampin ADP-ribosyltransferase gene (ARR-2; conferring resistance to rifampin), four beta-lactamase genes (blaADC-25, blaOXA-23, blaOXA-64, and blaPER-7; conferring resistance to beta-lactams), one chloramphenicol exporter gene (cmlA1; conferring resistance to chloramphenicol), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolide antibiotics], one ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics] and two sulfonamide resistance genes (sul1 and sul2; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 480561 is available (GenBank: VHEQ00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 480561 was isolated in 2017 from a human respiratory sample in Asia as part of a global surveillance program.
A. baumannii, strain MRSN 480561 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52244 was deposited as multi-locus sequence type (MLST) ST 25, sensitive to colistin and tetracycline and resistant to amikacin, ampicillin/sulbactam, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, gentamicin, imipenem, levofloxacin, meropenem, tobramycin and trimethoprim/sulfamethoxazole. Strain MRSN 480561 is reported to have five aminoglycoside transferase genes [aac(3)-IIa, aac(6')-Ian, aph(3'')-Ib, aph(6)-Id and armA; conferring resistance to various aminoglycosides], one rifampin ADP-ribosyltransferase gene (ARR-2; conferring resistance to rifampin), four beta-lactamase genes (blaADC-25, blaOXA-23, blaOXA-64, and blaPER-7; conferring resistance to beta-lactams), one chloramphenicol exporter gene (cmlA1; conferring resistance to chloramphenicol), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolide antibiotics], one ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics] and two sulfonamide resistance genes (sul1 and sul2; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 480561 is available (GenBank: VHEQ00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
肺杆菌（A. baumannii），菌株MRSN 480561于2017年从亚洲的人类呼吸样本中分离，作为全球监测计划的一部分.
a. Baumannii ，菌株MRSN 480561作为MRSN 鲍曼杆菌的一部分沉积，Baumannii 从BEI资源获得的多样性面板作为NR-52248. NR-52244沉积为多基因座序列（MLST）ST 25，对Colistin和Tetracycline敏感，抗Amikacin，Ampicillin / Sulbactam，Ceftakidime，Ceftrazone，Cefepime，Ciphoxacin，庆大霉素，infipenem，左氧氟沙星，Meropenem，Tawhamycin和Trimethoprim /磺胺甲恶唑.据报道，菌株MRSN 480561具有五种氨基糖苷类转移酶基因[ AAC （3） - IIA， AAC （6'） - IAN， APH （ 3''） - IB， APH （6）-ID和手臂 a;赋予各种氨基糖苷的抗性，一个利福平ADP-核糖基转移酶基因（ ARR -2;赋予利福平抗性抗性），四种β-内酰胺酶基因（ BLA ADC- 25 ， bla oxa-23 ， bla oxa-64 ，和 bla per-7 ;赋予β-内酰胺的耐药性，一种氯霉素出口基因（ cml a1;赋予氯霉素抗性），一种大环内德磷酸转移酶基因[ MPH （e）;赋予大环内酯抗生素的抗性]，一种ABC-F亚家族蛋白基因[ MSR （E）;赋予红霉素和链条B抗生素的耐药性和两个磺酰胺抗性基因（SUL 1和 SUL 2;赋予磺胺酰胺）. a的完整基因组. Baumannii ，菌株MRSN 480561可用（GenBank：）.
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-06-17
2022-06-17
2021-12-02
2022-03-22
2021-12-02
2022-04-01
2021-12-21
2025-03-18
2024-01-21
2021-10-31
2021-12-02
2021-12-21
2022-04-01